Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Neurorehabilitation|December 27, 2021
Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trialRozalina Dimitrova, Heakyung Kim, Jill Meilahn, et al.
Aesthetic Surgery Journal|April 26, 2026
Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy AdultsSanjay M Mallya, Paul Kostenuik, René Hopfinger, et al.
Neurology|May 3, 2023
Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety UpdateMitchell F Brin, Russell S Kirby, Anne Slavotinek, et al.
Toxins|May 26, 2023
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-AnalysisJoseph Jankovic, Jean Carruthers, Markus Naumann, et al.
JAAD International|November 30, 2023
Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysisMitchell F Brin, Koen De Boulle, Steven Liew, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 8, 2003
Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distributionDiane D-S Tang-Liu, K Roger Aoki, J Oliver Dolly, et al.
The FEBS Journal|May 22, 2012
Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxinOm P Edupuganti, Saak V Ovsepian, Jiafu Wang, et al.
The Journal of Urology|June 11, 2005
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month studyBrigitte Schurch, Marianne de Sèze, Pierre Denys, et al.
Cephalalgia : an International Journal of Headache|September 26, 2025
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female miceAaron J Schain, Diego Delgado Fajardo, Andrew M Strassman, et al.
Aesthetic Surgery Journal|March 20, 2025
A Controlled Phase 2b Trial to Assess the Efficacy and Safety of a Single Intervention of OnabotulinumtoxinA for Treating Masseter Muscle ProminenceSteven Liew, Derek Jones, Steven Dayan, et al.
Pageof 17